Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses.
Shuai ZhangLiwei ZhaoMengfei GuoPeng LiuSijing LiWei XieAi-Ling TianJonathan G PolHui ChenHui PanMisha MaoYumei LiLaurence ZitvogelYang JinOliver KeppGuido KroemerPublished in: Journal for immunotherapy of cancer (2023)
These findings underscore the potential utility of this screening system for the identification of immunostimulatory drugs with anticancer effects.